732-938-5545 [email protected]
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • Home
  • Contact Us
Central Compounding Pharmacy
  • About Us
    • FAQ
    • Benefits
    • Contact Us
  • Services
  • Vet Services
  • Treatment
    • What We Treat
    • Hormone Therapy for Women
    • Hormone Therapy for Men
  • Schedule an Appointment
    • Speak with Pharmacist
  • Resources
    • LDN Articles
    • What is LDN?
    • Privacy Policy
  • Refills
Select Page
Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes

Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes

by Doug LaRocca | Feb 25, 2019 | Central Compounding Pharmacy, LDN Articles

Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain SyndromesAbstractPain can have a devastating effect on the quality of life of patients in palliative medicine… click here for more.Source:...

Recent Posts

  • Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.
  • Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn’s disease: a pilot study.
  • Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes

Archives

  • April 2019
  • February 2019

Categories

  • Central Compounding Pharmacy
  • LDN Articles
  • FAQ
  • Privacy Policy
  • Sitemap
  • Contact Us
  • Blog
  • Facebook
  • Twitter
  • Instagram
  • RSS
©

 2023 Central Compounding Pharmacy · All Rights Reserved · ShoreSite Designs ShoreSite Web Designs, LLC